Efficacy and Safety of Nerivio for the Management of Amplified Musculoskeletal Pain Syndrome in Pediatric Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-01

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this trial is to learn how the Nerivio® device works to treat Amplified Musculoskeletal Pain Syndrome (AMPS) in children ages 8-18. Nerivio® is a wearable device that activates specific nerves in the upper arm. This causes a response from the brain that has been helpful for people who experience migrane headaches. The main questions this study aims to answer are:

* How well does the Nerivio® device help in reducing pain in children with AMPS?
* Does the use of the Nerivio® device help improve quality of life in children with AMPS?
* How satisfied are children and their families with the use of the Nerivio® device for treatment of AMPS?

Researchers will compare the use of the Nerivio® device with usual treatment for AMPS (including pain medications, physical therapy, and other interventions) to see how well the Nerivio® device helps control pain.

Participants will be in one of two groups, decided by:

* Those who are in the "control" group will use their usual practices to control pain.
* Those who are in the "intervention" group will use the Nerivio® device once every other day.

All participants in the "control group" will:

* Complete surveys and answer questions about their pain and how it affects their daily life
* Use their existing methods for pain control.

All participants in the "intervention" group will:

* Complete surveys and answer questions about their pain and how it affects their daily life
* Learn how to work the Nerivio® device and smartphone app.
* Use the Nerivio® device every other day (every 48 hours).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Use of Specially Designed Pediatric MR Coils on Clinical Scanners

NCT01795989

Healthy Volunteers Musculoskeletal Complication

COMPLETED

Microneedle Patch Study in Healthy Infants/Young Children

NCT03207763

Vaccination Skin Absorption

COMPLETED NA

VEPTR Implantation to Treat Children With Early Onset Scoliosis Without Rib Abnormalities

NCT00689533

Congenital Progressive Scoliosis Infantile

UNKNOWN

Detecting and Monitoring Scoliosis Without Radiography: Standard Radiographic Monitoring Program Versus Self-Screening with Momentum SpineTM

NCT06825611

Adolescent Idiopathic Scoliosis

NOT_YET_RECRUITING NA

Assessing Neurophysiological and Cognitive Function in School Children

NCT06209528

Pediatric ALL

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amplified Musculoskeletal Pain Syndrome (AMPS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Patients with AMPS in the control group will use their usual practices to control pain.

Group Type PLACEBO_COMPARATOR

Usual Care

Intervention Type OTHER

Patients will use their usual care to treat pain.

Intervention group

Patients in the experimental group will use the Nerivio(R) device once every 48 hours.

Group Type EXPERIMENTAL

Nerivio(R) Device

Intervention Type DEVICE

Patients will use the Nerivio(R) device once every 48 hours.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nerivio(R) Device

Patients will use the Nerivio(R) device once every 48 hours.

Intervention Type DEVICE

Usual Care

Patients will use their usual care to treat pain.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed diagnosis of AMPS by a medical provider experienced in pediatric pain management
* Chronic musculoskeletal pain ≥3 months
* Baseline pain intensity of ≥4 on a 0-10/10 Numeric Rating Scale (NRS)
* Able to comprehend and follow instructions for the device use
* Access to compatible smartphone or device to operate the Nerivio app
* Commit to a four-week treatment and data collection period
* Must be age 8 years - 18 years old

Exclusion Criteria

* Active autoimmune disease.
* Use of implantable electronic medical devices.
* Neurological disorders that impair study participation as determined by the enrolling provider.
* Severe Mood disorders
* Recent change in pain medications or psychotropic medications (within last 4 weeks)
* Currently or plan to be pregnant (Urine or blood HCG testing done upon enrollment)
* Inability to comply with study procedures or use the device as directed

Minimum Eligible Age

8 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No